Detailed inform­a­tion and a list of ref­er­ences can be found in Chapter 2.9 of the Fer­ti­PRO­TEKT book, “Indic­a­tions and fertility pre­ser­va­tion methods for onco­lo­gic­al and non-onco­lo­gic­al disorders”, which can be down­loaded free of charge.

Prognosis

2–3 new cases per 100,000 people occur annually and men are slightly more commonly affected with the ratio 3: 2. 2200 new cases were recorded in Germany in 2010 and young people are often affected.

Over recent decades, Hodgkin’s lymphoma has developed from an incurable disease to one of the most treatable malig­nan­cies in adults with out­stand­ing 5‑year survival rates.

+ SURVIVAL RATES IN WOMEN AND MEN ACCORDING TO THE AGE AT DIAGNOSIS

Age at initial diagnosis (years) 5‑year survival rate 15-year survival rate
18–29 96% 94%
30–39 95% 91%
40–49 93% 87%

damage to ovaries and testes caused by Chemo­ther­apy and/or radiotherapy

The chemo­ther­apy regimens used in Hodgkin’s lymphoma have differing effects on the gonads. The so-called intensive escalated BEACOPP therapy has a higher toxicity than the ABVD regimen. We also know that the damaging effect is greater in older women, since they already have fewer eggs than younger women.

+ PERCENTAGE OF WOMEN WHO STILL HAD A REGULAR MENSTRUAL CYCLE AFTER CHEMOTHERAPY — ACCORDING TO THE AGE AND THE ADMINISTERED CHEMOTHERAPY

Age Time of assessment 2x ABVD ABVD plus 2x escalated BEACOPP 6x escalated BEACOPP
18–29 years Imme­di­ately after chemotherapy 94% 100% 88%
At the time of ques­tion­ing (average: 46 months after treatment) 88% 95% 81%
30–45 years Imme­di­ately after chemotherapy 97% 90% 55%
At the time of ques­tion­ing (average: 46 months after treatment) 95% 75% 40%

Chemo­ther­apy par­tic­u­larly affects sperm devel­op­ment in men. The impact of the therapy on testoster­one pro­duc­tion, however, is low. Irra­di­ation of the testes is very harmful, even with minimal doses. However, irra­di­ation of the testic­u­lar area is rarely necessary.

Risk of meta­stas­is in the gonads

Several studies have sys­tem­at­ic­ally tried to detect tumour cells in frozen ovarian tissue. Evidence of Hodgkin’s lymphoma cells in ovarian tissue is hardly ever found, even in high-grade tumour stages. Hodgkin lymphoma is clas­si­fied as a disease with a low risk of metastasis.

Risks of fertility preservation

Fertility pre­ser­va­tion measures are usually only asso­ci­ated with low risks in Hodgkin’s lymphoma patients. The tumour cells are not dependent on hormones and the time available to carry out all pro­ced­ures is usually long enough. The risk of lymphoma cells being found in the gonads is low.

practical approach

Patients should be referred to a repro­duct­ive medical centre as soon as possible to allow a suf­fi­cient time frame for the imple­ment­a­tion of fertility pro­tec­tion measures.  A referral can be made even before the chemo­ther­apy regimen is agreed.

Basic procedure for per­form­ing fertility pro­tec­tion measures in women with Hodgkin’s lymphoma (POI = complete loss of ovarian function). As it is a simple procedure, men should generally be advised to have their sperm frozen, regard­less of age and chemo­ther­apy regimen.